Loomis, Sayles & Company’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-4,340
| Closed | -$10.9M | – | 1011 |
|
|
2017
Q1 | $10.9M | Buy |
4,340
+4,338
| +216,900% | +$10.9M | 0.03% | 404 |
|
|
2016
Q4 | $4K | Hold |
2
| – | – | ﹤0.01% | 938 |
|
|
2016
Q3 | $5K | Hold |
2
| – | – | ﹤0.01% | 887 |
|
|
2016
Q2 | $6K | Sell |
2
-5
| -71% | -$15K | ﹤0.01% | 829 |
|
|
2016
Q1 | $24K | Sell |
7
-4,864
| -100% | -$16.7M | ﹤0.01% | 709 |
|
|
2015
Q4 | $25M | Buy |
4,871
+227
| +5% | +$1.17M | 0.07% | 216 |
|
|
2015
Q3 | $14.8M | Buy |
4,644
+19
| +0.4% | +$60.4K | 0.04% | 361 |
|
|
2015
Q2 | $18.5M | Buy |
4,625
+677
| +17% | +$2.71M | 0.05% | 347 |
|
|
2015
Q1 | $15.8M | Sell |
3,948
-112
| -3% | -$447K | 0.04% | 394 |
|
|
2014
Q4 | $19.9M | Buy |
4,060
+1,070
| +36% | +$5.25M | 0.06% | 334 |
|
|
2014
Q3 | $12.2M | Buy |
+2,990
| New | +$12.2M | 0.04% | 462 |
|